SOX2 and glioblastoma: Previous studies in patient-derived specimens and tumorigenic-competent GBM cells showed upregulated REST expression for two- to five-fold as compared to normal [9,11], and high REST expression coincided with high levels of SOX2, which is known as a neural stem cell self-renewal regulator [10].